Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Independent Bank Corp
IBCP
$850M
| $3.98M | ﹤0.01% |
208,595
-9,583
| -4% | -$194K |
|
3827
Invesco Zacks Mid-Cap ETF
CZA
$193M
| $3.98M | ﹤0.01% |
49,732
-12,799
| -20% | -$1.12M |
|
|
WW
3828
DELISTED
WW International
WW
| $3.96M | ﹤0.01% |
1,007,987
+22,381
| +2% | +$136K |
|
|
QVCGA
3829
DELISTED
QVC Group Inc Series A
QVCGA
| $3.94M | ﹤0.01% |
39,204
-14,854
| -27% | -$2.15M |
|
3830
UFP Technologies
UFPT
$2.49B
| $3.94M | ﹤0.01% |
45,833
+30,792
| +205% | +$2.7M |
|
|
EMBJ
3831
Embraer S.A. ADS
EMBJ
$13.4B
| $3.93M | ﹤0.01% |
457,374
+20,582
| +5% | +$204K |
|
3832
Aspen Aerogels
ASPN
$485M
| $3.93M | ﹤0.01% |
425,923
+49,978
| +13% | +$605K |
|
|
JNCE
3833
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.93M | ﹤0.01% |
1,678,448
+48,526
| +3% | +$172K |
|
3834
VanEck Emerging Markets High Yield Bond ETF
HYEM
$528M
| $3.92M | ﹤0.01% |
232,776
-267,285
| -53% | -$4.68M |
|
|
JPXN
3835
iShares JPX-Nikkei 400 ETF
JPXN
$142M
| $3.92M | ﹤0.01% |
75,436
+1,458
| +2% | +$82.8K |
|
3836
Franklin Covey
FC
$229M
| $3.91M | ﹤0.01% |
86,237
+35,674
| +71% | +$1.77M |
|
3837
Pennant Group
PNTG
$1.37B
| $3.91M | ﹤0.01% |
375,653
+6,578
| +2% | +$94K |
|
|
TUP
3838
DELISTED
Tupperware Brands Corporation
TUP
| $3.91M | ﹤0.01% |
596,250
+52,987
| +10% | +$476K |
|
|
VFL
3839
DELISTED
abrdn National Municipal Income Fund
VFL
| $3.9M | ﹤0.01% |
358,174
+121,409
| +51% | +$1.45M |
|
3840
Enel Chile
ENIC
$6.27B
| $3.9M | ﹤0.01% |
2,824,977
+648,740
| +30% | +$964K |
|
3841
ANI Pharmaceuticals
ANIP
$1.76B
| $3.88M | ﹤0.01% |
120,857
+5,323
| +5% | +$182K |
|
|
FFIC
3842
DELISTED
Flushing Financial
FFIC
| $3.88M | ﹤0.01% |
200,140
-12,100
| -6% | -$258K |
|
3843
Invesco S&P 500 Equal Weight Real Estate ETF
RSPR
$100M
| $3.86M | ﹤0.01% |
128,956
+34,616
| +37% | +$1.19M |
|
|
NPKI
3844
NPK International
NPKI
$1.21B
| $3.85M | ﹤0.01% |
1,529,720
-77,642
| -5% | -$228K |
|
|
DMO
3845
Western Asset Mortgage Opportunity Fund
DMO
$120M
| $3.85M | ﹤0.01% |
346,098
+49,367
| +17% | +$591K |
|
3846
Madrigal Pharmaceuticals
MDGL
$11.7B
| $3.84M | ﹤0.01% |
59,064
-23,889
| -29% | -$1.66M |
|
|
RBCP
3847
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $3.84M | ﹤0.01% |
37,092
-13,630
| -27% | -$1.55M |
|
|
EDF
3848
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$168M
| $3.83M | ﹤0.01% |
1,039,127
+77,884
| +8% | +$347K |
|
|
EPIX
3849
DELISTED
ESSA Pharma
EPIX
| $3.83M | ﹤0.01% |
2,106,019
-1,563,661
| -43% | -$4.12M |
|
3850
DoubleVerify
DV
$2.04B
| $3.82M | ﹤0.01% |
139,806
+32,286
| +30% | +$832K |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.